Skip to main content
S 959 113th Congress Senate

Pharmaceutical Quality, Security, and Accountability Act

Official title: A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to compounding drugs.

Introduced: May 16, 2013 See on congress.gov
Health Administrative law and regulatory proceduresBusiness recordsDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulation
More subjectsShow fewer subjects
Federal preemptionFood and Drug Administration (FDA)Licensing and registrationsPrescription drugsRetail and wholesale tradesSmall businessState and local government operationsUser charges and feesVeterinary medicine and animal diseases
Sign in to write a letter Sign in to watch
This bill died when the 113th Congress ended
It never became law before the 113th Congress (2013–2014) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 19, 2013
Placed on Senate Legislative Calendar under General Orders. Calendar No. 89.
Jun 19, 2013
Committee on Health, Education, Labor, and Pensions. Reported by Senator Harkin with an amendment in the nature of a substitute and an amendment to the title. Without written report.
May 22, 2013
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
May 15, 2013
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
May 15, 2013
Introduced in Senate
 Amendments to this bill 4

Amendments propose changes to this bill. Members vote on amendments separately before the final bill vote. An agreed amendment becomes part of the bill; a failed amendment does not.

AmendmentSponsorPurposeStatusLatest action
SAMDT 1,829 Boozman, John – Pending –
SAMDT 1,828 Boozman, John – Pending –
SAMDT 1,827 Boozman, John – Pending –
SAMDT 1,826 Boozman, John – Pending –
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action June 19, 2013

Placed on Senate Legislative Calendar under General Orders. Calendar No. 89.

 Plain-English summary Congressional Research Service

Pharmaceutical Compounding Quality and Accountability Act - Sets forth provisions to revise the regulations regarding human compounding. Establishes requirements for animal drug compounding and biological product compounding. Requires the compounding manufacturers to: (1) register with the Secretary of Health and Human Services (HHS) annually, (2) report to the Secretary on the drugs it compounds, and (3) report serious adverse events associated with the use of compounded drugs. Requires the Secretary to assess establishment and reinspection fees.

 Related & companion bills 2
  • HR 3204 Related bill Drug Quality and Security Act
  • S 957 Related bill Drug Supply Chain Security Act
 Bill text 2 versions

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 1
All 1 Democratic 1
D
Warren, Elizabeth
Massachusetts · May 16, 2013
Cite this page click to expand
APA
U.S. Congress. (2026). S. 959: Pharmaceutical Quality, Security, and Accountability Act. 113th Congress. Open America. https://openamerica.io/bill/113-S-959/
MLA
"S. 959: Pharmaceutical Quality, Security, and Accountability Act." 113th Congress, 2026, Open America, https://openamerica.io/bill/113-S-959/.
Bluebook (legal)
S. 959, 113th Cong. (2026), https://openamerica.io/bill/113-S-959/.
Markdown link
[S. 959: Pharmaceutical Quality, Security, and Accountability Act](https://openamerica.io/bill/113-S-959/)
Report a problem